topiramate vs tirzepatide vs. Semaglutide: What You Should Know Cardiometabolic risk effects of weight‐loss
Description
According to the findings, 36% of current GLP-1 users report currently microdosing, 32% of users say they used to microdose in the past, but have stopped, and 32% say they have never microdosed
But youre also not trying to live like a monk
You might notice: The buzz around stars such as Elon Musk, whos dubbed Ozempic Santa for his transformation
What matters most is consistency and working with your provider to find the dose and routine that fit your body
